- Revenue up by 11% to 4.98 billion USD *
- Net profit after tax of 1,25 billion USD, up 11%
CSL Limited, the parent company of CSL Behring, today published its financial figures for the past half year (reporting date 31 December 2019). Net profit was a strong $1.25 billion on revenue of $4.98 billion*, an increase of 11 percent.
CSL’s Chief Executive Officer and Managing Director, Mr Paul Perreault said, “I am pleased to report a strong first-half result of the 2020 financial year. Our results reflect the focused execution of our strategy, robust demand for our differentiated medicines and a deep, inherent passion for meeting the evolving needs of our patients.”
More information on CSL's half-year results is available on the CSL global website at www.csl.com.
*With constant currency. More information and legal notice is included in the investor presentation.
